BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8416149)

  • 1. Molecular basis of epithelial tumorigenesis: the thyroid model.
    Wynford-Thomas D
    Crit Rev Oncog; 1993; 4(1):1-23. PubMed ID: 8416149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular basis of tumors arising in thyroid follicular cells].
    Wynford-Thomas D
    Ann Chir; 1999; 53(3):237-43. PubMed ID: 10339867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular biology of thyroid neoplasms.
    Satta MA; Nanni S; Della Casa S; Pontecorvi A
    Rays; 2000; 25(2):151-61. PubMed ID: 11370534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
    Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenes and antioncogenes involved in human thyroid carcinogenesis.
    Lazzereschi D; Mincione G; Coppa A; Ranieri A; Turco A; Baccheschi G; Pelicano S; Colletta G
    J Exp Clin Cancer Res; 1997 Sep; 16(3):325-32. PubMed ID: 9387909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic dysregulation in thyroid neoplasia.
    Kondo T; Asa SL; Ezzat S
    Endocrinol Metab Clin North Am; 2008 Jun; 37(2):389-400, ix. PubMed ID: 18502333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of genetic factors in the pathogenesis of thyroid neoplasms].
    Ferenc T; Maciaszczyk K; Gesing A; Lewiński A
    Postepy Hig Med Dosw; 1997; 51(4):367-84. PubMed ID: 9446100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic mutations in thyroid carcinoma.
    Taccaliti A; Boscaro M
    Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene profiling identifies genes specific for well-differentiated epithelial thyroid tumors.
    Puskas LG; Juhasz F; Zarva A; Hackler L; Farid NR
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(2):177-86. PubMed ID: 16171553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathogenesis of thyroid nodules and cancer.
    Moretti F; Nanni S; Pontecorvi A
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Dec; 14(4):517-39. PubMed ID: 11289733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Origin and progression of thyroid epithelial tumors: molecular and cellular mechanisms].
    Gire V; Wynford-Thomas D
    Arch Anat Cytol Pathol; 1998; 46(1-2):11-8. PubMed ID: 9754356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Ras transformation of human thyroid epithelial cells.
    Poghosyan Z; Wynford-Thomas D
    Methods Enzymol; 2006; 407():648-60. PubMed ID: 16757359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors.
    Dahia PL; Marsh DJ; Zheng Z; Zedenius J; Komminoth P; Frisk T; Wallin G; Parsons R; Longy M; Larsson C; Eng C
    Cancer Res; 1997 Nov; 57(21):4710-3. PubMed ID: 9354427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident.
    Nikiforov YE; Nikiforova MN; Gnepp DR; Fagin JA
    Oncogene; 1996 Aug; 13(4):687-93. PubMed ID: 8761289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic molecular biology in solid tumors--thyroid gland].
    Faksvåg Haugen DR; Varhaug JE; Akslen LA; Lillehaug JR
    Tidsskr Nor Laegeforen; 1998 May; 118(14):2199-203. PubMed ID: 9656818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of activating mutations in ras and gsp oncogenes in a cohort of nine patients with sporadic pediatric thyroid tumors.
    Pauws E; Tummers RF; Ris-Stalpers C; de Vijlder JJ; Voûte T
    Med Pediatr Oncol; 2001 Jun; 36(6):630-4. PubMed ID: 11344494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of follicular thyroid cancer.
    Farid NR; Zou M; Shi Y
    Endocrinol Metab Clin North Am; 1995 Dec; 24(4):865-83. PubMed ID: 8608782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions.
    Pavelić K; Dedivitis RA; Kapitanović S; Cacev T; Guirado CR; Danić D; Radosević S; Brkić K; Pegan B; Krizanac S; Kusić Z; Spaventi S; Bura M
    Mutat Res; 2006 Jul; 599(1-2):45-57. PubMed ID: 16698048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of molecular abnormalities leading to thyroid carcinogenesis: a 1993 perspective.
    Gagel RF
    Stem Cells; 1997; 15 Suppl 2():7-13. PubMed ID: 9368282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transgenic models of human thyroid pathologies: hyperfunctional adenoma, anaplastic cancer, differentiated cancer, hypothyroidism].
    Ledent C
    Bull Mem Acad R Med Belg; 1996; 151(2):195-201. PubMed ID: 9004925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.